SCHEMBL7232132

SCHEMBL7232132

CCCCC(=O)NC(=O)c1cccnc1N1CCN(Cc2ccccc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHIA Q9BZP6 1/20 0.49
TSHR P16473 1/20 0.48
HSD17B10 Q99714 1/20 0.48
HTR3E A5X5Y0 1/20 0.47
HTR3B O95264 1/20 0.47
HTR1A P08908 1/20 0.47
HTR2C P28335 1/20 0.47
HTR3A P46098 1/20 0.47
HTR3D Q70Z44 1/20 0.47
HTR3C Q8WXA8 1/20 0.47
HSD11B1 P28845 1/20 0.47
ABL1 P00519 1/20 0.46
RIN1 Q13671 1/20 0.46
CAPN1 P07384 1/20 0.45
CTSS P25774 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
HTR7 P34969 2/20 0.44
HDAC6 Q9UBN7 1/20 0.44
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7235837 0.89 TSHR (0.56) CHIATSHRHSD17B10HTR3EHTR3B
SCHEMBL7243416 0.88 MEN1 (0.52) CHIATSHRHSD17B10MEN1KMT2A
SCHEMBL7238934 0.83 L3MBTL1 (0.50) TSHRHSD17B10HTR1AKMT2AHTR7
SCHEMBL7238307 0.83 TSHR (0.48) CHIATSHRHSD17B10HTR3EHTR3B
SCHEMBL7242857 0.79 CHIA (0.61) CHIATSHRHSD17B10HTR2CCAPN1
SCHEMBL7241454 0.79 BCHE (0.57) TSHRHTR1AMEN1KMT2AMAPT
SCHEMBL7235226 0.79 HTR3E (0.61) TSHRHSD17B10HTR3EHTR3BHTR1A
SCHEMBL7241475 0.79 TSHR (0.50) CHIATSHRHSD17B10HSD11B1CAPN1
SCHEMBL7239461 0.79 GPR6 (0.48) TSHRHSD17B10MEN1KMT2AMAPT
SCHEMBL7241407 0.79 CAPN1 (0.65) CAPN1CTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562827-B1 For the treatment of diseases in which increased calpain activity occurs such as neurodegenerative diseases or neuronal damage are caused by ischemia, trauma or mass hemorrhages ABBOTT LABORATORIES 2003-05-13 US disclosed